Register

Please register here to gain access to the Continuing Medical Education courses

or sign in

 

Prolia® (denosumab) SmPC and UK Prescribing Information

Prolia summary of product characteristics (SmPC) 2010

UK Brief Prolia® Prescribing Information

Adverse events occurring in patients treated with Prolia®:

Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.gov.uk. Adverse events should also be reported to Amgen Limited on +44 (0) 1223 436712

You are leaving BoneAcademy.com

Redirecting

You are now leaving this website. This link will take you to a website containing content that Amgen and GSK cannot be held responsible for. You are solely responsible for your interactions with that website.

Amgen and GSK assume no responsibility for the site you are about to enter or its content.
©2010 Amgen Inc. All Rights Reserved

   

You are leaving BoneAcademy.com

Redirecting

You are now leaving this website.


©2010 Amgen Inc. All Rights Reserved